Top

Published in:

01-03-2011 | Editorial

Recent hot topics in contrast media

Author: Henrik S. Thomsen

Published in: European Radiology | Issue 3/2011

Abstract

This editorial reviews the way in which the facts related to the safety of iodinated and gadolinium based contrast agents have emerged over the last two decades. This is especially important given their ever increasing usage in modern computed tomographic (CT) and Magnetic resonance imaging (MRI) examinations. It also provides a very useful educational resume of this complex subject.

Thomsen HS, Archer JW, Schiermer L, Radensky PW (1998) The financial impact of Denmark’s decision to restrict the use of high-osmolar contrast media in intravascular radiographic procedures. Eur Radiol 8:321–322CrossRefPubMed

Tepel M, van der Giet M, Schwartzfeld C et al (2000) Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 343:180–184CrossRefPubMed

Thomsen HS (2001) Contrast-medium-induced nephrotoxicity: are all answers in for Acetylcysteine? Eur Radiol 11:2351–2353CrossRefPubMed

Ellis JH, Cohan RH (2009) Reducing the risk of contrast induced nephropathy. A perspective on the controversies. AJR Am J Roentgenol 192:1544–1549CrossRefPubMed

Aspelin P, Aubry P, Fransson SG et al (2003) Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 348:491–499CrossRefPubMed

Laskey W, Aspelin P, Davidson C et al (2009) Nephrotoxicity of iodixanol versus iopamidol in patients with chroinic disease and diabetes undergoing coronary angiographic procedures. Am Heart J 158:822–828CrossRefPubMed

Thomsen HS, Morcos SK (2006) Contrast-medium-induced nephropathy: is there a new consensus? A review of published guidelines. Eur Radiol 16:1835–1840

Heinrich MC, Häberle L, Müller V et al (2009) Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials. Radiology 250:68–86CrossRefPubMed

Reed M, Meier P, Tamhane UU et al (2009) The relative renal safety of iodixanol compared with low-osmolar contrast media: a meta-analysis of randomized controlled trials. JACC Cardiovasc Interv 2:645–654CrossRefPubMed

10.

Thomsen HS, Morcos SK (2008) Risk of contrast medium-induced nephropathy in high-risk patients undergoing MDCT—a pooled analysis of two randomized trials. Eur Radiol 18:891–897

11.

Hoppe H, Spagnuolo S, Froehlich JM et al (2010) Retrospective analysis of patients for development of nephrogenic systemic fibrosis following conventional angiography using gadolinium-based contrast agents. Eur Radiol 20:595–603CrossRefPubMed

12.

Thomsen HS, Almén T, Morcos SK et al (2002) Gadolinium-containing contrast media for radiographic examination: a position paper. Eur Radiol 12:2600–2605PubMed

13.

Thomsen HS (2004) Gadolinium-based contrast media may be nephrotoxic even at approved doses (case report). Eur Radiol 14:1654–1656PubMed

14.

Elmståhl B, Nyman U, Leander P et al (2006) Gadolinium contrast media are more nephrotoxic than iodine media. The importance of osmolality in direct renal artery injections. Eur Radiol 16:2712–2720CrossRefPubMed

15.

Reimer P, Vosshenrich R (2008) Off-label use of contrast agents. Eur Radiol 18:1096–1101CrossRefPubMed

16.

Thomsen HS (2006) Nephrogenic systemic fibrosis: a serious late adverse reaction to gadodiamide. Eur Radiol 16:2619–2621CrossRefPubMed

17.

Leiner T, Herborn C, Goyen M (2007) Nephrogenic systemic fibrosis is not exclusively associated with gadodiamide. Euro Radiol 17:1921–1923CrossRef

18.

Morcos SK (2010) Experimental studies investigating the pathophysiology of nephrogenic systemic fibrosis; what did we learn so far? Eur Radiol. doi:10.1007/s00330-010-1951-z PubMed

19.

Evans CH, Drouven BJ (1983) The promotion of collagen polymerization by lanthanide and calcium ions. Biochem J 213:751–758PubMed

20.

Brouven BJ, Evans CK (1986) Collagen fibrillogenesis in the presence of lathanides. J Biol Chim 261:11792–11797

21.

SMRM workshop on contrast enhanced magnetic resonance (1991) Discussion. Magn Reson Med 22:229–232CrossRef

22.

White GW, Gibby WA, Tweedle MF (2006) Comparison of Gd (DTPA-BMA) (Omniscan) versus Gd(HP-DO3A) (ProHance) relative to gadolinium retention in human bone tissue by inductively coupled plasma mass spectroscopy. Invest Radiol 41:272–8CrossRefPubMed

23.

Caravan P, Ellison JJ, McMurry TJ, Lauffer RB (1999) Gadolinium (III) chelates and MRI agents: Structure, dynamics and applications. Chem Rev 99:2293–2352

24.

Wadas TJ, Sherman CD, Miner JH et al (2010) The biodistribution of [153Gd]Gd-labeled magnetic resonance contrast agents in a transgenic mouse model of renal failure differs greatly from control mice. Magn Reson Med 64(5):1274–80. doi:10.1002/mrm.22553 CrossRefPubMed

25.

COMMISSION DECISION of 1.7.2010 concerning, in the framework of Article 31 of Directive 2001/83/EC of the European Parliament and of the Council, the marketing authorisations for Gadolinium-containing contrast agents for human use which contain one or more of the active substances “gadodiamide, gadopentetic acid, gadobenic acid, gadoxetic acid, gadoteridol, gadobutrol and gadoteric acid”. http://ec.europa.eu/health/documents/community-register/html/refh_others.htm . Accessed November 1st 2010

26.

Böhm I, Schild HH (2006) A practical guide to diagnose lesser-known immediate and delayed contrast media-induced adverse cutaneous reactions. Eur Radiol 16:1570–1579CrossRefPubMed

27.

Thomsen HS, Morcos SK (2004) Management of acute adverse reactions to contrast media. Eur Radiol 14:476–481CrossRefPubMed

28.

Morcos SK, Thomsen WJAW (2001) Prevention of generalized reactions to contrast media: a consensus report and guidelines. Eur Radiol 11:1720–1728CrossRefPubMed

29.

Lightfoot CB, Abraham RJ, Mammen T (2009) Survey of radiologist’s knowledge regarding the management of severe contrast material-induced allergic reactions. Radiology 251:691–696CrossRefPubMed

30.

Munechika H, Hiramatsu Y, Kudo S et al (2003) A prospective survey of delayed adverse reactions to iohexol in urography and computed tomography. Eur Radiol 13:185–194CrossRefPubMed

31.

Webb JAW, Stacul F, Thomsen HS, Morcos SK (2003) Late reactions to intravascular iodinated contrast media. Eur Radiol 13:181–184CrossRefPubMed

Title: Recent hot topics in contrast media
Author: Henrik S. Thomsen
Publication date: 01-03-2011
Publisher: Springer-Verlag
Published in: European Radiology / Issue 3/2011
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI: https://doi.org/10.1007/s00330-010-2026-x

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Recent hot topics in contrast media

Abstract

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2011

The real capabilities of contrast-enhanced ultrasound in the characterization of solid focal liver lesions

Editorial for anniversary issue of European Radiology

Dual-energy contrast-enhanced digital mammography: initial clinical results

Tractography of developing white matter of the internal capsule and corpus callosum in very preterm infants

Dynamic contrast-enhanced magnetic resonance imaging and pharmacokinetic models in prostate cancer

Paediatric cardiac computed tomography: a review of imaging techniques and radiation dose consideration